UB Paderborn / Katalog / Suche / in CDI

Assessing the safety of new drugs during pregnancy

British journal of dermatology (1951), 2018-01, Vol.178 (1), p.18-19

Hyrich, K.L.

2018

Link zum Volltext

Verfügbarkeit prüfen

The Role of Anti–Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Seminars in oncology, 2010-02, Vol.37 (1), p.11-19

2010

Link zum Volltext

Verfügbarkeit prüfen

SAT0577 Patient-Reported DAS28 in Rheumatoid Arthritis: Its Reliability in A Longitudinal Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.878-878

2016

Link zum Volltext

Verfügbarkeit prüfen

THU0234 Clinical Experience and Decision Making in Relation To The Use of Biologics in Adult JIA

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.272-273

2016

Link zum Volltext

Verfügbarkeit prüfen

OP0236 Whole Transcriptome Investigation of Response To Anti-TNF Treatment in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.147-147

2016

Link zum Volltext

Verfügbarkeit prüfen

OP0013 Prediction of Non-Response To Methotrexate Therapy in The Rheumatoid Arthritis Medication Study (RAMS)

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.57-58

2016

Link zum Volltext

Verfügbarkeit prüfen

AB0915 No Association between Etanercept and New or Worsening Atopic Dermatitis in Children with Jia: an Analysis from the BSPAR Etanercept Cohort Study: Table 1

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1103-1103

2014

Link zum Volltext

Verfügbarkeit prüfen

FRI0557 Standardised Mortality Rates Are Increased in Patients with Severe Juvenile Idiopathic Arthritis: Table 1

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.588-588

2014

Link zum Volltext

Verfügbarkeit prüfen

OP0029 The Risk of Serious Infections in Patients Receiving Rituximab for Rheumatoid Arthritis: Table 1

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.70-71

2014

Link zum Volltext

Verfügbarkeit prüfen

AB0915 No Association between Etanercept and New or Worsening Atopic Dermatitis in Children with Jia: an Analysis from the BSPAR Etanercept Cohort Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1103

2014

Link zum Volltext

Verfügbarkeit prüfen

FRI0557 Standardised Mortality Rates Are Increased in Patients with Severe Juvenile Idiopathic Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.588

2014

Link zum Volltext

Verfügbarkeit prüfen

SAT0345 Lifestyle, Clinical and Psychosocial Predictors of Good Response to Methotrexate Therapy in the Rheumatoid Arthritis Medication Study (RAMS)

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.783-784

2015

Link zum Volltext

Verfügbarkeit prüfen

FRI0145 Choice and Effectiveness of Tocilizumab Among Patients with Rheumatoid Arthritis: An Observational Study from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.474-475

2015

Link zum Volltext

Verfügbarkeit prüfen

SAT0009 Investigation of Differential Methylation as A Potential Biomarker of Methotrexate Response in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.667-667

2016

Link zum Volltext

Verfügbarkeit prüfen

SAT0148 Does depression affect response to anti-tumour necrosis factor-α therapy in patients with rheumatoid arthritis (RA)? Results from the british society for rheumatology biologics register (BSRBR)

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.521-522

2013

Link zum Volltext

Verfügbarkeit prüfen

AB0436 Patient acceptable symptom state in rheumatoid arthritis patients starting methotrexate correlates with age and patient reported outcomes

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.662-662

2013

Link zum Volltext

Verfügbarkeit prüfen

OP0029 The Risk of Serious Infections in Patients Receiving Rituximab for Rheumatoid Arthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.70

2014

Link zum Volltext

Verfügbarkeit prüfen

THU0531 The Initial Treatment of Systemic Juvenile Idiopathic Arthritis: An International Collaboration Among 7 Registries

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.392-393

2015

Link zum Volltext

Verfügbarkeit prüfen

SAT0052 Influence of Immunogenicity and Drug Levels on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab and Etanercept: A Uk-Based Prospective Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.608-608

2014

Link zum Volltext

Verfügbarkeit prüfen

SAT0230 The Influence of Anti-TNF or Rituximab on Cancer Incidence in Patients with Rheumatoid Arthritis Who Have HAD A Prior Malignancy

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.674-674

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

The pharmacogenomics journal, 2014-04, Vol.14 (2), p.171-175

2014

Link zum Volltext

Verfügbarkeit prüfen

OP0190 Personalized Genetic Medicine: Amino Acid Positions 11, 71 and 74 in HLA-DRB1 PREDICT Disease Severity, Treatment Response and Mortality in Rheumatoid Arthritis; Multi-Centre Prospective Cohort Studies

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.134-134

2014

Link zum Volltext

Verfügbarkeit prüfen

THU0307 Validation of JADAS in international league against rheumatism (ILAR) subtypes of juvenile idiopathic arthritis (JIA)

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.259-260

2013

Link zum Volltext

Verfügbarkeit prüfen

FRI0342 Does exclusion of the ESR from JADAS affect validity in the clinical setting in assessment of new-onset juvenile inflammatory arthritis?

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.429-430

2013

Link zum Volltext

Verfügbarkeit prüfen

FRI0325 Methotrexate survival in children with JIA: Results from the childhood arthritis prospective study (CAPS)

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.423-424

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Assessing the safety of new drugs during pregnancy

The Role of Anti–Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

SAT0577 Patient-Reported DAS28 in Rheumatoid Arthritis: Its Reliability in A Longitudinal Study

THU0234 Clinical Experience and Decision Making in Relation To The Use of Biologics in Adult JIA

OP0236 Whole Transcriptome Investigation of Response To Anti-TNF Treatment in Rheumatoid Arthritis

OP0013 Prediction of Non-Response To Methotrexate Therapy in The Rheumatoid Arthritis Medication Study (RAMS)

AB0915 No Association between Etanercept and New or Worsening Atopic Dermatitis in Children with Jia: an Analysis from the BSPAR Etanercept Cohort Study: Table 1

FRI0557 Standardised Mortality Rates Are Increased in Patients with Severe Juvenile Idiopathic Arthritis: Table 1

OP0029 The Risk of Serious Infections in Patients Receiving Rituximab for Rheumatoid Arthritis: Table 1

AB0915 No Association between Etanercept and New or Worsening Atopic Dermatitis in Children with Jia: an Analysis from the BSPAR Etanercept Cohort Study

FRI0557 Standardised Mortality Rates Are Increased in Patients with Severe Juvenile Idiopathic Arthritis

SAT0345 Lifestyle, Clinical and Psychosocial Predictors of Good Response to Methotrexate Therapy in the Rheumatoid Arthritis Medication Study (RAMS)

FRI0145 Choice and Effectiveness of Tocilizumab Among Patients with Rheumatoid Arthritis: An Observational Study from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

SAT0009 Investigation of Differential Methylation as A Potential Biomarker of Methotrexate Response in Patients with Rheumatoid Arthritis

SAT0148 Does depression affect response to anti-tumour necrosis factor-α therapy in patients with rheumatoid arthritis (RA)? Results from the british society for rheumatology biologics register (BSRBR)

AB0436 Patient acceptable symptom state in rheumatoid arthritis patients starting methotrexate correlates with age and patient reported outcomes

OP0029 The Risk of Serious Infections in Patients Receiving Rituximab for Rheumatoid Arthritis

THU0531 The Initial Treatment of Systemic Juvenile Idiopathic Arthritis: An International Collaboration Among 7 Registries

SAT0052 Influence of Immunogenicity and Drug Levels on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab and Etanercept: A Uk-Based Prospective Study

SAT0230 The Influence of Anti-TNF or Rituximab on Cancer Incidence in Patients with Rheumatoid Arthritis Who Have HAD A Prior Malignancy

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

OP0190 Personalized Genetic Medicine: Amino Acid Positions 11, 71 and 74 in HLA-DRB1 PREDICT Disease Severity, Treatment Response and Mortality in Rheumatoid Arthritis; Multi-Centre Prospective Cohort Studies

THU0307 Validation of JADAS in international league against rheumatism (ILAR) subtypes of juvenile idiopathic arthritis (JIA)

FRI0342 Does exclusion of the ESR from JADAS affect validity in the clinical setting in assessment of new-onset juvenile inflammatory arthritis?

FRI0325 Methotrexate survival in children with JIA: Results from the childhood arthritis prospective study (CAPS)

Suchergebnisse filtern